Adrian Roth
Impact in
- Hepatology top 2%
- Liver physiology and pathology
- Pharmacology top 1%
- Pharmacogenetics and Drug Metabolism
- Drug-Induced Hepatotoxicity and Protection
Papers in
-
- Pluripotent Stem Cells Research 9
-
- 3D Printing in Biomedical Research 22
- Innovative Microfluidic and Catalytic Techniques Innovation 4
- Co-authors
- Thomas P. Singer (11 shared papers)Laura Suter‐Dick (12 shared papers)Franziska Boess (9 shared papers)Deborah G. Nguyen (1 shared paper)Candace Crogan‐Grundy (1 shared paper)Justin B. Robbins (1 shared paper)Sharon C. Presnell (1 shared paper)Juergen Funk (2 shared papers)
- Journals
- PLoS ONE (8 papers)Toxicology Letters (4 papers)Toxicological Sciences (3 papers)Advanced Science (2 papers)Current Opinion in Toxicology (2 papers)
- Partner nations
- SwitzerlandUnited StatesGermany
In The Last Decade
Adrian Roth
67 papers receiving 2.9k citations
Adrian Roth's Hit Papers
Peers
Comparison fields: 5 of 133
- Hepatology 349
- Pharmacology 397
- Biomedical Engineering 1.3k
- Biophysics 94
- Small Animals 107
Countries citing papers authored by Adrian Roth
This map shows the geographic impact of Adrian Roth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adrian Roth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adrian Roth more than expected).
Fields of papers citing papers by Adrian Roth
This network shows the impact of papers produced by Adrian Roth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adrian Roth. The network helps show where Adrian Roth may publish in the future.
Co-authors
The 25 scholars most cited alongside Adrian Roth, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 71 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 327 | |
| 2 | 2017 | 238 | |
| 3 | 2013 | 232 | |
| 4 | 2019 | 157 | |
| 5 | The evolving role of investigative toxicology in the pharmaceutical industry Hit paper breakdown → | 2023 | 156 |
| 6 | 2008 | 129 | |
| 7 | 2019 | 113 | |
| 8 | 2013 | 102 | |
| 9 | 2021 | 94 | |
| 10 | 2020 | 75 | |
| 11 | 2014 | 75 | |
| 12 | 2012 | 72 | |
| 13 | 2016 | 71 | |
| 14 | 2020 | 67 | |
| 15 | 2013 | 65 | |
| 16 | 2021 | 61 | |
| 17 | 1999 | 59 | |
| 18 | 2008 | 58 | |
| 19 | Phytoestrogen kaempferol (3,4',5,7-tetrahydroxyflavone) protects PC12 and T47D cells from beta-amyloid-induced toxicity. | 1999 | 58 |
| 20 | 2016 | 50 |
About Adrian Roth
Adrian Roth is a scholar working on Molecular Biology, Biomedical Engineering, Pharmacology, Oncology and Hepatology, having authored 71 papers that have together received 3.0k indexed citations. Recurring topics across this work include 3D Printing in Biomedical Research (22 papers), Pharmacogenetics and Drug Metabolism (12 papers), Liver physiology and pathology (9 papers), Pluripotent Stem Cells Research (9 papers), Drug-Induced Hepatotoxicity and Protection (7 papers), Computational Drug Discovery Methods (5 papers), Innovative Microfluidic and Catalytic Techniques Innovation (4 papers) and Hormonal Regulation and Hypertension (3 papers). The work is most often cited by research in Hepatology (349 citations), Pharmacology (397 citations), Biomedical Engineering (1.3k citations), Biophysics (94 citations) and Small Animals (107 citations). Adrian Roth has collaborated with scholars based in Switzerland, United States and Germany. Frequent co-authors include Thomas P. Singer, Laura Suter‐Dick, Franziska Boess, Deborah G. Nguyen, Candace Crogan‐Grundy, Justin B. Robbins, Sharon C. Presnell, Juergen Funk, Urs Meyer and Thomas Weiser. Their work appears in journals such as PLoS ONE, Toxicology Letters, Toxicological Sciences, Advanced Science and Current Opinion in Toxicology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.